These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. [The neuroleptic malignant syndrome in an adolescent. Its treatment with dantrolene, bromocryptin and diazepam]. Real Rodríguez B; Ruibal JL; Grande Rodríguez S; Sueiro Pita B An Esp Pediatr; 1996 Jan; 44(1):60-2. PubMed ID: 8849063 [No Abstract] [Full Text] [Related]
10. The neuroleptic malignant syndrome: occurrence in a 15-year-old boy and recovery with bromocriptine therapy. Tenenbein M Pediatr Neurosci; 1985-1986; 12(3):161-4. PubMed ID: 3870437 [TBL] [Abstract][Full Text] [Related]
12. A hazardous side effect of neuroleptics: diagnosis and treatment. Epperly TD; McGlaughlin VG; Leo KU Geriatrics; 1990 Aug; 45(8):58-62. PubMed ID: 1974232 [TBL] [Abstract][Full Text] [Related]
13. Severe neuroleptic malignant syndrome: successful treatment with high-dose lorazepam and diazepam: a case report. Tsai MC; Huang TL Chang Gung Med J; 2010; 33(5):576-80. PubMed ID: 20979709 [TBL] [Abstract][Full Text] [Related]
15. [Neuroleptic malignant syndrome and related conditions]. Amore M; Montanari M Minerva Psichiatr; 1992; 33(4):259-83. PubMed ID: 1363674 [TBL] [Abstract][Full Text] [Related]
16. Successful treatment of a complicated case of neuroleptic malignant syndrome. Lappa A; Podestà M; Capelli O; Castagna A; Di Placido G; Alampi D; Semeraro F Intensive Care Med; 2002 Jul; 28(7):976-7. PubMed ID: 12122539 [TBL] [Abstract][Full Text] [Related]
17. The neuroleptic malignant syndrome: agent and host interaction. Shalev A; Munitz H Acta Psychiatr Scand; 1986 Apr; 73(4):337-47. PubMed ID: 2873715 [TBL] [Abstract][Full Text] [Related]
19. The neuroleptic malignant syndrome. A priority system. Neppe VM S Afr Med J; 1984 Mar; 65(13):523-5. PubMed ID: 6143410 [TBL] [Abstract][Full Text] [Related]